Immutep Limited
PRRUF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $948 | $3,148 | $1,731 | $2,111 |
| % Growth | -69.9% | 81.8% | -18% | – |
| Cost of Goods Sold | $18,040 | $25,331 | $21,110 | $996 |
| Gross Profit | -$17,092 | -$22,183 | -$19,379 | $1,115 |
| % Margin | -1,802.8% | -704.7% | -1,119.4% | 52.8% |
| R&D Expenses | $18,040 | $25,331 | $21,110 | $20,436 |
| G&A Expenses | $2,205 | $4,234 | $4,050 | $4,802 |
| SG&A Expenses | $2,205 | $4,234 | $4,050 | $4,802 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $20,245 | $29,564 | $25,161 | $25,239 |
| Operating Income | -$37,337 | -$51,747 | -$44,540 | -$43,564 |
| % Margin | -3,938.3% | -1,644% | -2,572.9% | -2,063.9% |
| Other Income/Exp. Net | $17,809 | $14,685 | $23,051 | $22,336 |
| Pre-Tax Income | -$19,528 | -$11,189 | -$21,488 | -$21,228 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$19,528 | -$22,377 | -$21,488 | -$21,228 |
| % Margin | -2,059.8% | -710.9% | -1,241.3% | -1,005.7% |
| EPS | -0.013 | -0.015 | -0.018 | -0.018 |
| % Growth | 13% | 13% | 0% | – |
| EPS Diluted | -0.013 | -0.015 | -0.018 | -0.018 |
| Weighted Avg Shares Out | 1,458,538 | 1,453,080 | 1,213,899 | 1,196,884 |
| Weighted Avg Shares Out Dil | 1,458,557 | 1,453,080 | 1,216,191 | 1,196,884 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,065 | $1,560 | $1,883 | $2,000 |
| Interest Expense | $0 | $0 | $20 | $11 |
| Depreciation & Amortization | $1,055 | $23 | $1,083 | $996 |
| EBITDA | -$18,242 | -$26,393 | -$22,346 | -$22,198 |
| % Margin | -1,924.1% | -838.5% | -1,290.8% | -1,051.7% |